✦ LIBER ✦

Docetaxel and zoledronic acid in patients with metastatic hormone-refractory prostate cancer

✍ Scribed by Dimitri Vordos; Bernard Paule; Francis Vacherot; Yves Allory; Laurent Salomon; Andras Hoznek; René Yiou; Dominique Chopin; Claude Clément Abbou; Alexandre De La Taille

Book ID: 109050705
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 70 KB
Volume: 94
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-4096.2004.04919.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly high-dose calcitriol and docetaxe

Weekly high-dose calcitriol and docetaxel in patients with metastatic hormone-refractory prostate cancer previously exposed to docetaxel

✍ Roberto Petrioli; Alessandra Pascucci; Edoardo Francini; Stefania Marsili; Angel 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Docetaxel-based chemotherapy with zoledr

Docetaxel-based chemotherapy with zoledronic acid and prednisone in hormone refractory prostate cancer: Factors predicting response and survival

✍ Rishi Nayyar; Nitin Sharma; Narmada P Gupta 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

Docetaxel, low-dose estramustine, and do

Docetaxel, low-dose estramustine, and doxifluridine in hormone-refractory metastatic prostate cancer

✍ Yoshihiro Wada; Ken Kikuchi; Wataru Takahashi; Jiro Honda; Juro Nakanishi; Koich 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 409 KB

Intermittent docetaxel therapy with estr

Intermittent docetaxel therapy with estramustine for hormone-refractory prostate cancer in Japanese patients

✍ Norihito Soga; Manabu Kato; Kouhei Nishikawa; Yoshihiro Hasegawa; Yasushi Yamada 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 305 KB

Treatment of androgen-independent, hormo

Treatment of androgen-independent, hormone-refractory prostate cancer with docetaxel in Japanese patients

✍ Yasuhide Miyoshi; Hiroji Uemura; Masafumi Nakamura; Hisashi Hasumi; Shinpei Sugi 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 210 KB

Combined use of zoledronic acid and 153S

Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases

✍ Marnix G. E. H. Lam; Amel Dahmane; Wil H. M. Stevens; Peter P. van Rijk; John M. 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 243 KB